Tübinger Diabetes Mellitus Database (TUEDID)

Recruiting now

Conditions studied: Diabetes Mellitus

In brief

Diabetes mellitus is a widespread disease with increasing prevalence worldwide. Patients with diabetes can develop multiple late complications such as neuropathy, retinopathy, nephropathy and cardiovascular comorbidities. So far, there are no reliable predictive tools or markers to estimate if, when and to what extent a patient with diabetes develops late complications. For the patients quality of life and for health economic reasons an improved risk assessment would be desirable. The prospective TUEDID study will characterize diabetic patients to look out for parameters the predict progression of diabetes and its complications.

Key facts

Study ID

NCT03658512

Run by

University Hospital Tuebingen

People needed

1000

Starts

2018-02-05

Expected to finish

2035-02-01

Last updated by the study team

2026-07-09

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• >18 years

You may not qualify if…

• no written informed consent

Where it is running

• University of Tuebingen, Internal medicine IV — Tübingen, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.